Viewing nowGlucitagl Tablet 100 mg (Sitagliptin Hydrochloride Hydrate)
Sitagliptin Hydrochloride Hydrate 113.37mg
Tablet · Prescription medication
Kips Biopharma Co., Ltd.

MFDS item code 202102832 · Approved 2021.03.31 · Insurance code 693202460
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used in conjunction with diet and exercise to help control blood glucose levels in patients with type 2 diabetes. It can also be administered as monotherapy, and in cases where sufficient blood glucose control is difficult in patients with no prior experience of diabetes medication therapy, it can be used in combination with metformin. Additionally, if blood glucose control is challenging with monotherapies such as sulfonylureas, metformin, thiazolidinediones, or insulin, this medication can be added for combined therapy. If blood glucose control is still insufficient with complex combination therapies, this medication can be added to enhance treatment efficacy. This drug is used to improve blood glucose control in various situations.
Administer 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because dose adjustment according to renal function is required, evaluation of renal function is recommended before starting treatment with this medicine and periodically thereafter. 1. No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is necessary in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily in patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered without regard to the timing of dialysis.
This medication can cause severe allergic reactions, so if symptoms such as skin rash, difficulty breathing, or swelling of the face or neck appear after taking it, you should immediately stop taking it and consult a doctor. There is a risk of developing serious inflammation of the pancreas (pancreatitis) while taking this medication, so if sudden abdominal pain, vomiting, or nausea occur, you should promptly inform healthcare professionals. Patients with type 1 diabetes or diabetic ketoacidosis should not take this medication, and patients who have experienced an allergic reaction to this medication or its components should also avoid it. Patients with impaired renal function may require dosage adjustments, so if you have kidney disease or reduced kidney function, you should consult a doctor before taking it. Side effects such as upper respiratory tract infections, nasopharyngitis, headache, diarrhea, nausea may occur during treatment. If symptoms are severe or persist for a long time, you should inform your doctor. The risk of hypoglycemia may increase when taking this medication with other antidiabetic agents, particularly insulin or sulfonylureas, hence blood glucose levels should be regularly monitored, and if necessary, dosage adjustments should be made. This medication can cause rare side effects, such as severe joint pain or the skin disease bullous pemphigoid. If severe joint pain or skin blisters or rashes develop, immediate medical attention is necessary. The safety of this medication during pregnancy or breastfeeding has not been established, so it's not recommended to take it. Its efficacy and safety in children under 18 years have not been adequately confirmed. Elderly patients may have impaired renal function, making it important to adjust the dosage and regularly monitor kidney function. In cases of overdose, you should immediately visit a medical institution for appropriate treatment. This medication can be partially removed by hemodialysis, so dialysis treatment may be considered if necessary.
Anaphylaxis, angioedema, Stevens-Johnson syndrome, acute pancreatitis, hypoglycemia, upper respiratory infection, nasopharyngitis, headache, diarrhea, abdominal pain, nausea, peripheral edema, constipation, vomiting, arthralgia accompanied by severe conditions and disabilities, bullous pemphigoid, myalgia, limb pain, back pain, interstitial lung disease, pruritus, thrombocytopenia, rhabdomyolysis, elevated liver enzyme levels, acute renal failure, dyspepsia, dizziness, increased serum triglycerides, gastritis, pneumonia, diabetes complications, metabolic acidosis, falls, cardiac arrest, weight loss, hypertension, hypernatremia, erectile dysfunction
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air and moisture, and it is recommended to keep it at a temperature between 1 and 30 degrees Celsius. Proper storage helps to maintain the effectiveness of the medication.
Bright yellow-orange round film-coated tablets
100 tablets/bottle, 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSitagliptin Hydrochloride Hydrate 113.37mg
Tablet · Prescription medication
Kips Biopharma Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.